ID

31734

Descripción

The Efficacy and Safety of Vardenafil in the Treatment of Pulmonary Arterial Hypertension; ODM derived from: https://clinicaltrials.gov/show/NCT00718952

Link

https://clinicaltrials.gov/show/NCT00718952

Palabras clave

Versiones (1)
  1. 24/9/18 24/9/18 -
Titular de derechos de autor

See clinicaltrials.gov

Subido en

24 de septiembre de 2018

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Pulmonary Hypertension NCT00718952

Inglés

Eligibility Pulmonary Hypertension NCT00718952

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
subjects aged 12-65.
Descripción

Age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
confirmed idiopathic pulmonary hypertension, connective tissue disease associated pulmonary hypertension, congenital heart disease(with eisenmenger syndrome) associated pulmonary hypertension.
Descripción

Idiopathic pulmonary hypertension | Pulmonary arterial hypertension associated with connective tissue disease | Pulmonary arterial hypertension associated with congenital heart disease | Eisenmenger Complex

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0152171
UMLS CUI [2]
C3697982
UMLS CUI [3]
C3697119
UMLS CUI [4]
C0013743
baseline 6-minutes walking distance 150m-550m.
Descripción

6-Minute Walk Test Meter Quantity

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0430515
UMLS CUI [1,2]
C0475209
UMLS CUI [1,3]
C1265611
who pulmonary hypertension function ii-iii with non-responder to calcium channel blockers.
Descripción

Pulmonary Hypertension WHO classification | Therapy non-responder Calcium Channel Blockers

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0020542
UMLS CUI [1,2]
C4267671
UMLS CUI [2,1]
C0919875
UMLS CUI [2,2]
C0006684
documented written informed consent.
Descripción

Informed Consent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
the other types of pulmonary hypertension.
Descripción

Pulmonary Hypertension Type Other

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0020542
UMLS CUI [1,2]
C0332307
UMLS CUI [1,3]
C0205394
subjects who refuse to subscribe written informed consents or can't cooperate with the trial well.
Descripción

Informed Consent Refused | Protocol Compliance Limited

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0021430
UMLS CUI [1,2]
C1705116
UMLS CUI [2,1]
C0525058
UMLS CUI [2,2]
C0439801
subjects with serious acute or chronic disease involved liver, kidney, and brain or have to use potent cyp3a4-inhibitor or nitrate to treat the underlying diseases.
Descripción

Disease Serious Involvement Liver | Disease Serious Involvement Kidney | Disease Serious Involvement Brain | Chronic disease Serious Involvement Liver | Chronic disease Serious Involvement Kidney | Chronic disease Serious Involvement Brain | CYP3A4 Inhibitor Primary disorders | Nitrate Primary disorders

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C0205404
UMLS CUI [1,3]
C1314939
UMLS CUI [1,4]
C0023884
UMLS CUI [2,1]
C0012634
UMLS CUI [2,2]
C0205404
UMLS CUI [2,3]
C1314939
UMLS CUI [2,4]
C0022646
UMLS CUI [3,1]
C0012634
UMLS CUI [3,2]
C0205404
UMLS CUI [3,3]
C1314939
UMLS CUI [3,4]
C0006104
UMLS CUI [4,1]
C0008679
UMLS CUI [4,2]
C0205404
UMLS CUI [4,3]
C1314939
UMLS CUI [4,4]
C0023884
UMLS CUI [5,1]
C0008679
UMLS CUI [5,2]
C0205404
UMLS CUI [5,3]
C1314939
UMLS CUI [5,4]
C0022646
UMLS CUI [6,1]
C0008679
UMLS CUI [6,2]
C0205404
UMLS CUI [6,3]
C1314939
UMLS CUI [6,4]
C0006104
UMLS CUI [7,1]
C3830624
UMLS CUI [7,2]
C0277554
UMLS CUI [8,1]
C0028125
UMLS CUI [8,2]
C0277554
subjects who are currently treated with sildenafil for pah or taking sildenafil or tadalafil.
Descripción

Sildenafil Pulmonary arterial hypertension | sildenafil | tadalafil

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0529793
UMLS CUI [1,2]
C2973725
UMLS CUI [2]
C0529793
UMLS CUI [3]
C1176316
other contraindications in package insert.
Descripción

Package Insert Containing Medical contraindications

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0030174
UMLS CUI [1,2]
C0332256
UMLS CUI [1,3]
C1301624
Volver a la parte superior de la página

Similar models

Eligibility Pulmonary Hypertension NCT00718952

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
subjects aged 12-65.
boolean
C0001779 (UMLS CUI [1])
Idiopathic pulmonary hypertension | Pulmonary arterial hypertension associated with connective tissue disease | Pulmonary arterial hypertension associated with congenital heart disease | Eisenmenger Complex
Item
confirmed idiopathic pulmonary hypertension, connective tissue disease associated pulmonary hypertension, congenital heart disease(with eisenmenger syndrome) associated pulmonary hypertension.
boolean
C0152171 (UMLS CUI [1])
C3697982 (UMLS CUI [2])
C3697119 (UMLS CUI [3])
C0013743 (UMLS CUI [4])
6-Minute Walk Test Meter Quantity
Item
baseline 6-minutes walking distance 150m-550m.
boolean
C0430515 (UMLS CUI [1,1])
C0475209 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])
Pulmonary Hypertension WHO classification | Therapy non-responder Calcium Channel Blockers
Item
who pulmonary hypertension function ii-iii with non-responder to calcium channel blockers.
boolean
C0020542 (UMLS CUI [1,1])
C4267671 (UMLS CUI [1,2])
C0919875 (UMLS CUI [2,1])
C0006684 (UMLS CUI [2,2])
Informed Consent
Item
documented written informed consent.
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Pulmonary Hypertension Type Other
Item
the other types of pulmonary hypertension.
boolean
C0020542 (UMLS CUI [1,1])
C0332307 (UMLS CUI [1,2])
C0205394 (UMLS CUI [1,3])
Informed Consent Refused | Protocol Compliance Limited
Item
subjects who refuse to subscribe written informed consents or can't cooperate with the trial well.
boolean
C0021430 (UMLS CUI [1,1])
C1705116 (UMLS CUI [1,2])
C0525058 (UMLS CUI [2,1])
C0439801 (UMLS CUI [2,2])
Disease Serious Involvement Liver | Disease Serious Involvement Kidney | Disease Serious Involvement Brain | Chronic disease Serious Involvement Liver | Chronic disease Serious Involvement Kidney | Chronic disease Serious Involvement Brain | CYP3A4 Inhibitor Primary disorders | Nitrate Primary disorders
Item
subjects with serious acute or chronic disease involved liver, kidney, and brain or have to use potent cyp3a4-inhibitor or nitrate to treat the underlying diseases.
boolean
C0012634 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
C1314939 (UMLS CUI [1,3])
C0023884 (UMLS CUI [1,4])
C0012634 (UMLS CUI [2,1])
C0205404 (UMLS CUI [2,2])
C1314939 (UMLS CUI [2,3])
C0022646 (UMLS CUI [2,4])
C0012634 (UMLS CUI [3,1])
C0205404 (UMLS CUI [3,2])
C1314939 (UMLS CUI [3,3])
C0006104 (UMLS CUI [3,4])
C0008679 (UMLS CUI [4,1])
C0205404 (UMLS CUI [4,2])
C1314939 (UMLS CUI [4,3])
C0023884 (UMLS CUI [4,4])
C0008679 (UMLS CUI [5,1])
C0205404 (UMLS CUI [5,2])
C1314939 (UMLS CUI [5,3])
C0022646 (UMLS CUI [5,4])
C0008679 (UMLS CUI [6,1])
C0205404 (UMLS CUI [6,2])
C1314939 (UMLS CUI [6,3])
C0006104 (UMLS CUI [6,4])
C3830624 (UMLS CUI [7,1])
C0277554 (UMLS CUI [7,2])
C0028125 (UMLS CUI [8,1])
C0277554 (UMLS CUI [8,2])
Sildenafil Pulmonary arterial hypertension | sildenafil | tadalafil
Item
subjects who are currently treated with sildenafil for pah or taking sildenafil or tadalafil.
boolean
C0529793 (UMLS CUI [1,1])
C2973725 (UMLS CUI [1,2])
C0529793 (UMLS CUI [2])
C1176316 (UMLS CUI [3])
Package Insert Containing Medical contraindications
Item
other contraindications in package insert.
boolean
C0030174 (UMLS CUI [1,1])
C0332256 (UMLS CUI [1,2])
C1301624 (UMLS CUI [1,3])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial